Literature DB >> 10075758

Halohydrins and polyols derived from antirrhinoside: structural revisions of muralioside and epimuralioside

.   

Abstract

Treatment of the iridoid glucoside antirrhinoside (1) with pyridinium chloride in dimethylformamide gave rise to the two possible trans-halohydrins, linarioside (4) and isolinarioside (5). Pyridinium bromide gave the two analogous bromohydrins. It is shown that the iridoid glucosides 8-epi-muralioside from Linaria arcusangeli and 7,8-epi-antirrhinoside from Linaria dalmatica are both identical with isolinarioside, and therefore, these names are redundant. The structure of muralioside isolated from Cymbalaria muralis is revised to that of its 8-epimer (8), while the structure of an isomeric, new iridoid glucoside from Paulownia tomentosa has been elucidated to be 7beta-hydroxyharpagide (3), the structure originally assigned to 8. In addition, 7alpha-hydroxyharpagide (2), the known product from the base-catalyzed hydrolytic opening of 1, has been isolated from Antirrhinum majus and thus shown to be a natural product.

Entities:  

Year:  1999        PMID: 10075758     DOI: 10.1021/np980358x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  The distribution of two major Iridoids in different organs of Antirrhinum majus L. at selected stages of development.

Authors:  Clifford W Beninger; Renée R Cloutier; Mario A Monteiro; Bernard Grodzinski
Journal:  J Chem Ecol       Date:  2007-03-02       Impact factor: 2.626

2.  Iridoid glycoside variation in the invasive plant Dalmatian toadflax, Linaria dalmatica (Plantaginaceae), and sequestration by the biological control agent, Calophasia lunula.

Authors:  Mary A Jamieson; M Deane Bowers
Journal:  J Chem Ecol       Date:  2010-01       Impact factor: 2.626

Review 3.  Astonishing diversity of natural surfactants: 7. Biologically active hemi- and monoterpenoid glycosides.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2006-01       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.